These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10755202)

  • 1. Guanabenz combination therapy inhibits sympathetic nerve activity and regresses left ventricular hypertrophy.
    Miyajima E; Shigemasa T; Endo T; Hishiki S; Kawano Y
    Cardiovasc Drugs Ther; 2000 Feb; 14(1):61-6. PubMed ID: 10755202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central and peripheral blockade of the sympathetic nervous system.
    Weber MA; Drayer JI
    Am J Med; 1984 Oct; 77(4A):110-8. PubMed ID: 6148889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Centrally-acting antihypertensive drugs].
    Takishita S; Yamazato M
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():591-5. PubMed ID: 15171442
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effects of heart rate variability and smoothness index on the reversal of hypertensive left ventricular hypertrophy].
    Wang HB; Shi Q; Zhang C
    Zhonghua Yi Xue Za Zhi; 2011 Mar; 91(12):832-5. PubMed ID: 21600164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of guanabenz, alpha 2 central agonist, on the activity of the sympathetic nervous system during dynamic and isometric physical exercise].
    Fariello R; Agabiti-Rosei E; Alicandri C; Romanelli G; Muiesan G; Renzetti I
    Minerva Cardioangiol; 1984 May; 32(5):273-9. PubMed ID: 6382054
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of lisinopril vs hydralazine on left ventricular hypertrophy and ambulatory blood pressure monitoring in essential hypertension.
    Fogari R; Zoppi A; Mugellini A; Tettamanti F; Lusardi P; Corradi L
    Eur Heart J; 1995 Aug; 16(8):1120-5. PubMed ID: 8665975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular mass predicted by a single reading of ambulatory blood pressure in essential hypertension.
    Ohmori S; Matsumura K; Kajioka T; Fukuhara M; Abe I; Fujishima M
    Hypertens Res; 2000 Jul; 23(4):311-6. PubMed ID: 10912766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of losartan and spironolactone on left ventricular mass and heart sympathetic activity in prehypertensive obese subjects: a 16-week randomized trial.
    Amador N; Encarnación JJ; Guízar JM; Rodríguez L; López M
    J Hum Hypertens; 2005 Apr; 19(4):277-83. PubMed ID: 15674406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased sympathetic nervous system activity and its therapeutic reduction in arterial hypertension, portal hypertension and heart failure.
    Esler M; Kaye D
    J Auton Nerv Syst; 1998 Oct; 72(2-3):210-9. PubMed ID: 9851571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of antihypertensive therapy with guanabenz and propranolol on renal vascular resistance and left ventricular mass.
    Mosley C; O'Connor DT; Taylor A; Slutsky RA; Cervenka J
    J Cardiovasc Pharmacol; 1984; 6 Suppl 5():S757-61. PubMed ID: 6084120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the sympathetic nervous system in the alcohol-guanabenz hemodynamic interaction.
    Abdel-Rahman AA; Carroll RG; el-Mas MM
    Can J Physiol Pharmacol; 1992 Sep; 70(9):1217-24. PubMed ID: 1362923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Beta-Blockers in the Treatment of Hypertension.
    Cruickshank JM
    Adv Exp Med Biol; 2017; 956():149-166. PubMed ID: 27957711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left ventricular mass and heart sympathetic activity after renal transplantation in children and young adults.
    Guízar-Mendoza JM; Amador-Licona N; Lozada EE; Rodriguez L; Gutiérrez-Navarro M; Dubey-Ortega LA; Trejo-Bellido J; Encarnación Jde J; Ruiz-Jaramillo Mde L
    Pediatr Nephrol; 2006 Oct; 21(10):1413-8. PubMed ID: 16909241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recovery of cardiac norepinephrine concentration and tyrosine hydroxylase activity by the central alpha2-adrenoceptor agonist guanabenz in rats with aortic constriction.
    Takechi S; Nomura A; Shimono H; Katoh K; Kakinoki S; Jin EZ; Akutsu M; Kitabatake A
    J Cardiovasc Pharmacol; 1999 Mar; 33(3):409-13. PubMed ID: 10069676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitrendipine vs. captopril in essential hypertension: effects on circadian blood pressure and left ventricular hypertrophy.
    Machnig T; Henneke KH; Engels G; Pongratz G; Schmalzl M; Gellert J; Bachmann K
    Cardiology; 1994; 85(2):101-10. PubMed ID: 7954561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive effect of felodipine associated with persistent sympathetic activation and minimal regression of left ventricular hypertrophy.
    Leenen FH; Holliwell DL
    Am J Cardiol; 1992 Mar; 69(6):639-45. PubMed ID: 1531566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term calcium antagonist treatment of human hypertension with mibefradil or amlodipine increases sympathetic nerve activity.
    Lindqvist M; Kahan T; Melcher A; Ekholm M; Hjemdahl P
    J Hypertens; 2007 Jan; 25(1):169-75. PubMed ID: 17143189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of changes in sympathetic nerve activity and heart rate in essential hypertensive patients induced by amlodipine and nifedipine.
    Hamada T; Watanabe M; Kaneda T; Ohtahara A; Kinugawa T; Hisatome I; Fujimoto Y; Yoshida A; Shigemasa C
    J Hypertens; 1998 Jan; 16(1):111-8. PubMed ID: 9533424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aliskiren improves blood pressure control and prevents cardiac damage in high-risk hypertensive subjects.
    Mazza A; Montemurro D; Zuin M; Schiavon L; Zorzan S; Chondrogiannis S; Ferretti A; Ramazzina E; Rubello D
    Minerva Cardioangiol; 2013 Aug; 61(4):461-9. PubMed ID: 23846012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of guanabenz on blood pressure responses to posture and exercise.
    Dziedzic SW; Elijovich F; Felton K; Yeager K; Krakoff LR
    Clin Pharmacol Ther; 1983 Feb; 33(2):151-5. PubMed ID: 6337003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.